Options
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
Fecha de emisión
2019
Autor(es)
Camins A.
Ettcheto M.
Busquets O.
Manzine P.R.
Castro-Torres R.D.
Beas-Zarate C.
Verdaguer E.
Sureda F.X.
Bulló M.
Olloquequi J.
Auladell C.
Folch J.
DOI
10.1080/13543784.2019.1552677
Temas
Alzheimer’s disease
glucagon
glucagon-like peptide...
glucose-dependent ins...
type 2 diabetes
gastric inhibitory po...
glucagon like peptide...
glucagon receptor ago...
gastric inhibitory po...
glucagon like peptide...
glucagon receptor
hormone receptor
Alzheimer disease
Article
human
late onset disorder
nonhuman
Alzheimer disease
animal
drug development
molecularly targeted ...
pathophysiology
procedures
Alzheimer Disease
Animals
Drug Development
Glucagon-Like Peptide...
Humans
Molecular Targeted Th...
Receptors, Gastrointe...
Receptors, Glucagon
Archivo(s)